Tag:
CT-011
Latest Headlines
Latest Headlines
CureTech's positive lymphoma study triggers $69M Teva deal
Encouraged by the successful conclusion of a mid-stage lymphoma study, Teva Pharmaceutical is tightening its hold on CureTech. The pharma company is investing an additional $19 million into the
